Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels
- 1 April 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 148 (3) , 309-315
- https://doi.org/10.1016/0014-2999(88)90108-2
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL36830, HL07260, HL29566, RRI070)
This publication has 11 references indexed in Scilit:
- Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veinsEuropean Journal of Pharmacology, 1985
- Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogsBiochemical Pharmacology, 1985
- Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125ITetrahedron Letters, 1984
- Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analoguesBritish Journal of Pharmacology, 1983
- Synthesis of thromboxane A2 analogs—2Tetrahedron, 1983
- Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human plateletsJournal of Medicinal Chemistry, 1982
- Carbocyclic thromboxane A2Journal of the American Chemical Society, 1980
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- The synthesis of prostaglandin endoperoxide analogsTetrahedron Letters, 1975
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959